Clinical Trials in Los Angeles

Showing 6861-6880 of 12,794 trials

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

NCT00060086

RATIONALE: Pomegranate juice may contain substances that decrease or slow the rise of prostate-specific antigen (PSA) levels and may be effective in delaying or preventing recurrent prostate cancer. PURPOSE: This phase II trial is studying how well pomegranate juice works in decreasing or slowing the rise of PSA levels in patients who have undergone radiation therapy or surgery for prostate cancer.

Prostate Cancer

Jonsson Comprehensive Cancer Center47 participantsStarted Nov 2004

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)

NCT01810939

The purpose of this study was to evaluate the efficacy and safety of patiromer (investigational drug) in the treatment of hyperkalemia (high serum potassium). The study also evaluated the effect of withdrawing patiromer treatment and assessed whether chronic treatment with patiromer prevented the recurrence of hyperkalemia. The safety of patiromer treatment was also evaluated.

Chronic Kidney Disease (CKD)Hyperkalemia (HK)

Relypsa, Inc.243 participantsStarted Feb 2013

Azusa, California, United States • Los Angeles, California, United States • Sacramento, California, United States +55 more locations

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)

Find Trials by Condition in Los Angeles

Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

A Study To Monitor Long-Term Treatment With PF-00547659

Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1

A Study of Atezolizumab in Advanced Solid Tumors